Madison biotech company using $10M in recent funding to build therapeutics By: Milwaukee Business Journal via Business Journals August 25, 2020 at 14:50 PM EDT According to Vascugen, vascular diseases afflict hundreds of millions of people worldwide. Read More >> Related Stocks: Harbor Disruptive Innovation ETF